S
Shionogi & Co.
Osaka, Japan
Founded 1878 TSE: 4507
About
Infectious disease pharma with nanoparticle research
Company Details
- Type
- public
- Employees
- 5500+
- Funding
- Public
Key Products
- Xofluza
- Cabenuva
Infectious disease pharma with nanoparticle research